Abstract
Summary
Campral is a brand name of Acamprosate, and Acamprosate is sold under the brand name Campral, Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analogue of the amino acid neurotransmitter γ-aminobutyric acid and the amino acid neuromodulator taurine. Its chemical name is calcium acetylaminopropane sulfonate. Each Campral® tablet contains acamprosate calcium 333 mg, equivalent to 300 mg of acamprosate. Inactive ingredients in Campral tablets include: crospovidone, microcrystalline cellulose, magnesium silicate, sodium starch glycolate, colloidal anhydrous silica, magnesium stearate, talc, propylene glycol and Eudragit L 30 D or equivalent. Sulfites were used in the synthesis of the drug substance and traces of residual sulfites may be present in the drug product.
LPI (LP Information)' newest research report, the “Acamprosate Industry Forecast” looks at past sales and reviews total world Acamprosate sales in 2022, providing a comprehensive analysis by region and market sector of projected Acamprosate sales for 2023 through 2029. With Acamprosate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acamprosate industry.
This Insight Report provides a comprehensive analysis of the global Acamprosate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acamprosate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Acamprosate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acamprosate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acamprosate.
The global Acamprosate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acamprosate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acamprosate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acamprosate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acamprosate players cover Merck Group, Zydus Pharmaceuticals, Mylan, Teva and Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Acamprosate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
333 mg Delayed Release Tablet
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Group
Zydus Pharmaceuticals
Mylan
Teva
Glenmark Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Acamprosate market?
What factors are driving Acamprosate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acamprosate market opportunities vary by end market size?
How does Acamprosate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acamprosate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Acamprosate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Acamprosate by Country/Region, 2018, 2022 & 2029
2.2 Acamprosate Segment by Type
2.2.1 333 mg Delayed Release Tablet
2.2.2 Others
2.3 Acamprosate Sales by Type
2.3.1 Global Acamprosate Sales Market Share by Type (2018-2023)
2.3.2 Global Acamprosate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Acamprosate Sale Price by Type (2018-2023)
2.4 Acamprosate Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Acamprosate Sales by Application
2.5.1 Global Acamprosate Sale Market Share by Application (2018-2023)
2.5.2 Global Acamprosate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Acamprosate Sale Price by Application (2018-2023)
3 Global Acamprosate by Company
3.1 Global Acamprosate Breakdown Data by Company
3.1.1 Global Acamprosate Annual Sales by Company (2018-2023)
3.1.2 Global Acamprosate Sales Market Share by Company (2018-2023)
3.2 Global Acamprosate Annual Revenue by Company (2018-2023)
3.2.1 Global Acamprosate Revenue by Company (2018-2023)
3.2.2 Global Acamprosate Revenue Market Share by Company (2018-2023)
3.3 Global Acamprosate Sale Price by Company
3.4 Key Manufacturers Acamprosate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acamprosate Product Location Distribution
3.4.2 Players Acamprosate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Acamprosate by Geographic Region
4.1 World Historic Acamprosate Market Size by Geographic Region (2018-2023)
4.1.1 Global Acamprosate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Acamprosate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Acamprosate Market Size by Country/Region (2018-2023)
4.2.1 Global Acamprosate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Acamprosate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Acamprosate Sales Growth
4.4 APAC Acamprosate Sales Growth
4.5 Europe Acamprosate Sales Growth
4.6 Middle East & Africa Acamprosate Sales Growth
5 Americas
5.1 Americas Acamprosate Sales by Country
5.1.1 Americas Acamprosate Sales by Country (2018-2023)
5.1.2 Americas Acamprosate Revenue by Country (2018-2023)
5.2 Americas Acamprosate Sales by Type
5.3 Americas Acamprosate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acamprosate Sales by Region
6.1.1 APAC Acamprosate Sales by Region (2018-2023)
6.1.2 APAC Acamprosate Revenue by Region (2018-2023)
6.2 APAC Acamprosate Sales by Type
6.3 APAC Acamprosate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Acamprosate by Country
7.1.1 Europe Acamprosate Sales by Country (2018-2023)
7.1.2 Europe Acamprosate Revenue by Country (2018-2023)
7.2 Europe Acamprosate Sales by Type
7.3 Europe Acamprosate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acamprosate by Country
8.1.1 Middle East & Africa Acamprosate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Acamprosate Revenue by Country (2018-2023)
8.2 Middle East & Africa Acamprosate Sales by Type
8.3 Middle East & Africa Acamprosate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acamprosate
10.3 Manufacturing Process Analysis of Acamprosate
10.4 Industry Chain Structure of Acamprosate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acamprosate Distributors
11.3 Acamprosate Customer
12 World Forecast Review for Acamprosate by Geographic Region
12.1 Global Acamprosate Market Size Forecast by Region
12.1.1 Global Acamprosate Forecast by Region (2024-2029)
12.1.2 Global Acamprosate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Acamprosate Forecast by Type
12.7 Global Acamprosate Forecast by Application
13 Key Players Analysis
13.1 Merck Group
13.1.1 Merck Group Company Information
13.1.2 Merck Group Acamprosate Product Portfolios and Specifications
13.1.3 Merck Group Acamprosate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Group Main Business Overview
13.1.5 Merck Group Latest Developments
13.2 Zydus Pharmaceuticals
13.2.1 Zydus Pharmaceuticals Company Information
13.2.2 Zydus Pharmaceuticals Acamprosate Product Portfolios and Specifications
13.2.3 Zydus Pharmaceuticals Acamprosate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zydus Pharmaceuticals Main Business Overview
13.2.5 Zydus Pharmaceuticals Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Acamprosate Product Portfolios and Specifications
13.3.3 Mylan Acamprosate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Acamprosate Product Portfolios and Specifications
13.4.3 Teva Acamprosate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Glenmark Pharmaceuticals
13.5.1 Glenmark Pharmaceuticals Company Information
13.5.2 Glenmark Pharmaceuticals Acamprosate Product Portfolios and Specifications
13.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Glenmark Pharmaceuticals Main Business Overview
13.5.5 Glenmark Pharmaceuticals Latest Developments
14 Research Findings and Conclusion